IRIS UniCatt

Biolato, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.312
EU - Europa 2.090
AS - Asia 1.975
SA - Sud America 445
AF - Africa 55
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.250
SG - Singapore 972
DE - Germania 573
CN - Cina 520
SE - Svezia 390
BR - Brasile 383
IT - Italia 341
FR - Francia 128
IE - Irlanda 123
GB - Regno Unito 120
UA - Ucraina 114
ID - Indonesia 81
IN - India 79
FI - Finlandia 77
VN - Vietnam 76
RU - Federazione Russa 70
BD - Bangladesh 38
TR - Turchia 36
CA - Canada 34
HK - Hong Kong 30
PL - Polonia 27
AR - Argentina 26
BE - Belgio 26
KR - Corea 25
JP - Giappone 24
ZA - Sudafrica 22
IQ - Iraq 16
NL - Olanda 15
ES - Italia 14
AT - Austria 12
LT - Lituania 11
PK - Pakistan 11
SA - Arabia Saudita 10
MX - Messico 9
IR - Iran 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
CZ - Repubblica Ceca 7
PE - Perù 7
RO - Romania 7
CI - Costa d'Avorio 6
CL - Cile 6
DZ - Algeria 6
EC - Ecuador 6
EG - Egitto 6
GR - Grecia 6
KE - Kenya 6
DK - Danimarca 5
JM - Giamaica 5
PY - Paraguay 5
UZ - Uzbekistan 5
VE - Venezuela 5
AU - Australia 4
EU - Europa 4
BO - Bolivia 3
IL - Israele 3
JO - Giordania 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MA - Marocco 3
MD - Moldavia 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
CG - Congo 2
CO - Colombia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
IS - Islanda 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
MY - Malesia 2
PH - Filippine 2
RE - Reunion 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
EE - Estonia 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PW - Palau 1
QA - Qatar 1
Totale 6.883
Salva come PNG Salva come JPEG
Città #
Singapore 469
Chandler 322
Ashburn 266
New York 173
Dublin 123
Beijing 116
Dallas 95
Rome 88
Hefei 82
Los Angeles 77
Jakarta 75
Milan 71
Jacksonville 64
San Mateo 51
Nanjing 49
Chicago 48
Munich 46
Wilmington 46
Boston 44
Cattolica 41
Helsinki 38
Dearborn 35
Frankfurt am Main 35
Moscow 35
São Paulo 34
Marseille 31
Santa Clara 29
Princeton 28
The Dalles 27
Brussels 26
Hong Kong 25
Seoul 25
Ho Chi Minh City 24
Kent 24
Ann Arbor 22
Hanoi 20
London 20
Nürnberg 19
Woodbridge 19
Tokyo 18
Nuremberg 17
Redwood City 17
Saint Petersburg 17
Turku 17
Augusta 16
Izmir 15
Nanchang 15
Atlanta 14
Bremen 14
Buffalo 14
Houston 14
Johannesburg 14
Seattle 14
Falls Church 13
Denver 12
Montreal 12
Tianjin 12
Brooklyn 11
Changsha 11
Rio de Janeiro 11
Boardman 10
Dhaka 10
Hebei 10
Kraków 10
Norwalk 10
Shenyang 10
Baghdad 9
Bexley 9
Fairfield 9
Phoenix 9
Poplar 9
Amsterdam 8
Falkenstein 8
Guarulhos 8
Istanbul 8
Kunming 8
Lauterbourg 8
Lawrence 8
Warsaw 8
Brasília 7
Düsseldorf 7
Goiânia 7
Guangzhou 7
Lancaster 7
Mumbai 7
North Bergen 7
Orem 7
Palermo 7
Stockholm 7
Toronto 7
Washington 7
Abidjan 6
Belo Horizonte 6
Brno 6
Jiaxing 6
Lappeenranta 6
Leawood 6
Lima 6
Portland 6
Portsmouth 6
Totale 3.467
Salva come PNG Salva come JPEG
Nome #
A phase II study of sunitinib in advanced hepatocellular carcinoma 244
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 219
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 213
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 165
Vanishing-recurrent benign liver lesions 159
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 158
Liver transplantation in patients with alcoholic liver disease: A retrospective study 154
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 153
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 143
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 141
[The treatment of hepatocellular carcinoma: an update] 140
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 132
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 131
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 130
Severe giant cell arteritis associated with essential thrombocythaemia. 129
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 129
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 124
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 122
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 120
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 114
A giant calcified hepatic mass 110
Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind 104
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 101
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 100
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 100
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 97
Acute HEV hepatitis: clinical and laboratory diagnosis 96
Clinical impact of comorbidities in an Italian NAFLD cohort 91
Ventricular thrombosis during sorafenib therapy for advanced hepatocellular carcinoma 90
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 89
Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia 89
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 88
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 84
Proposal of a new evidence based definition of Early Allograft Failure to identify patients who needs early retransplant and call for a prospective external validation study 82
Correlation of the transaminases alteration with the clinical severity of patients with COVID-19: A meta-analysis of the first global outbreak 82
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 82
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 82
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 81
Post-liver transplant intrahepatic cholestasis: etiology, clinical presentation, therapy 80
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 78
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 78
Starvation hepatitis and refeeding-induced hepatitis: mechanism, diagnosis, and treatment 77
Fatty liver and drugs: the two sides of the same coin 77
Prognostic ability of BCLC-B subclassification in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 77
ORGANIZATIONAL AND ECONOMIC ISSUES RELATED TO THE INTRODUCTION OF BOCEPREVIR IN THE TREATMENT OF PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN ITALY 76
Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI 76
Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach 74
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 73
A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series 73
ELF TEST IS A RELIABLE NON INVASIVE TEST FOR FIBROSIS IN NAFLD SUBJECTS 71
Liver transplantation for drug-induced acute liver failure 70
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 69
Tumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature review 69
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection 68
Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all 66
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 65
FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION 64
FREQUENCY OF AND REASONS BEHIND NON-LISTING IN ADULT PATIENTS REFERRED FOR LIVER TRANSPLANTATION 63
Frequency of and reasons behind non-listing in adult patients referred for liver transplantation: Results from a retrospective study 63
Correction to: Acute liver failure in Still’s disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI (BMC Gastroenterology, (2021), 21, 1, (317), 10.1186/s12876-021-01878-3) 62
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 61
Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins? 60
Minimum platelet count threshold before invasive procedures in cirrhosis: Evolution of the guidelines 60
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 59
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 58
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 57
HEPATOMA ARTERIAL-EMBOLISATION PROGNOSTIC SCORE PREDICTS PROGRESSION IN HEPATOCELLULAR CARCINOMA TREATED BY RADIOFREQUENCY ABLATION PLUS TRANSARTERIAL CHEMOEMBOLIZATION 49
THE 15 AND 30 MINUTES SAMPLING OF 13C-BREATH TESTING ARE ABLE TO PREDICT SEVERE HEPATIC FIBROSIS AND SEVERITY OF LIVER DISEASE 46
Upper limits of downstaging for hepatocellular carcinoma in liver transplantation 46
Liver functional reserve and survival after sunitinib therapy in cirrhotic patients with advanced hepatocellular carcinoma 45
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 45
Severe Cholestatic Hepatitis due to Temozolomide: An Adverse Drug Effect to Keep in Mind. Case Report and Review of Literature 44
HEPARANASE IN NASH: IS IT AN USEFUL MARKER OF FIBROGENESIS? 42
Abdominal angina 28
Corrigendum to "Acute hepatitis caused by a natural lipid-lowering product: When "alternative" medicine is no "alternative" at all" [J Hepatol 50 (2009) 1273-1277] (DOI:10.1016/j.jhep.2009.02.021) 23
GAPO syndrome: a comprehensive examination and review of 105 clinical cases 10
Totale 6.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.616
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021133 0 0 0 0 0 10 25 9 33 13 36 7
2021/2022406 14 23 9 49 36 16 15 69 14 17 65 79
2022/20231.070 132 110 55 144 93 157 63 94 103 33 69 17
2023/2024708 48 171 26 46 34 109 45 33 13 40 47 96
2024/20251.415 31 29 125 55 107 54 42 61 204 131 310 266
2025/20262.117 567 111 270 412 536 221 0 0 0 0 0 0
Totale 6.970